These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 26896038

  • 1. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP, Sorensen LL, Pozios I, Chu L, Eng J, Abraham MR, Abraham TP, Kamel IR, Zimmerman SL.
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [Abstract] [Full Text] [Related]

  • 2. Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy.
    Hindieh W, Weissler-Snir A, Hammer H, Adler A, Rakowski H, Chan RH.
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794137
    [Abstract] [Full Text] [Related]

  • 3. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R, Lairez O, Boudou N, Méjean S, Lhermusier T, Dumonteil N, Berry M, Cognet T, Massabuau P, Elbaz M, Rousseau H, Galinier M, Carrié D.
    Arch Cardiovasc Dis; 2013 Aug; 106(8-9):440-7. PubMed ID: 23906680
    [Abstract] [Full Text] [Related]

  • 4. Contrast-Enhanced Echocardiographic Measurement of Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Comparison with Standard Echocardiography and Cardiac Magnetic Resonance.
    Urbano-Moral JA, Gonzalez-Gonzalez AM, Maldonado G, Gutierrez-Garcia-Moreno L, Vivancos-Delgado R, De Mora-Martin M, Rodriguez-Palomares JF, Evangelista-Masip A.
    J Am Soc Echocardiogr; 2020 Sep; 33(9):1106-1115. PubMed ID: 32564979
    [Abstract] [Full Text] [Related]

  • 5. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM, Lakdawala NK, Powell AJ, Evans SP, Cirino AL, Orav EJ, MacRae CA, Colan SD, Ho CY.
    Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
    [Abstract] [Full Text] [Related]

  • 6. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M, Agler D, Lytle BW, Lever HM, Desai MY.
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Webb J, Villa A, Bekri I, Shome J, Teall T, Claridge S, Jackson T, Porter B, Ismail TF, Di Giovine G, Rinaldi CA, Carr-White G, Al-Fakih K, Razavi R, Chiribiri A.
    Am J Cardiol; 2017 May 01; 119(9):1450-1455. PubMed ID: 28267963
    [Abstract] [Full Text] [Related]

  • 8. Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR.
    Florian A, Masci PG, De Buck S, Aquaro GD, Claus P, Todiere G, Van Cleemput J, Lombardi M, Bogaert J.
    JACC Cardiovasc Imaging; 2012 Jul 01; 5(7):702-11. PubMed ID: 22789938
    [Abstract] [Full Text] [Related]

  • 9. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP, Costabel JP, Asch FM, Sciancalepore A, Kuschnir P, Huguet M, Tobon-Gomez C, Frangi AF, Ronderos R.
    Echocardiography; 2016 Mar 01; 33(3):431-6. PubMed ID: 26525462
    [Abstract] [Full Text] [Related]

  • 10. [Characteristics of the inferior wall hypertrophy in hypertrophic cardiomyopathy patients with contrast echocardiography].
    Liu Z, Zhang W, Jing X, Xiao L, Huang H.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2018 Feb 25; 35(1):92-98. PubMed ID: 29745607
    [Abstract] [Full Text] [Related]

  • 11. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H, Seidelmann SB, Vigneault D, Abbasi SA, Yang E, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Jerosch-Herold M, Bluemke DA, Ho C, Neilan TG.
    J Cardiovasc Magn Reson; 2017 Dec 28; 19(1):107. PubMed ID: 29284499
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
    Bois JP, Geske JB, Foley TA, Ommen SR, Pellikka PA.
    Am J Cardiol; 2017 Feb 15; 119(4):643-650. PubMed ID: 27956002
    [Abstract] [Full Text] [Related]

  • 13. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T, Iwanaga Y, Yasuda M, Kawamura T, Miyaji Y, Morooka H, Miyazaki S.
    Int J Cardiovasc Imaging; 2016 Apr 15; 32(4):613-20. PubMed ID: 26589516
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR, Karur GR, Connelly KA, Yan RT, Kirpalani A, Wald R, Jimenez-Juan L, Jacob JR, Deva DP, Yan AT.
    Indian Heart J; 2018 Apr 15; 70(1):75-81. PubMed ID: 29455792
    [Abstract] [Full Text] [Related]

  • 15. Discordance interpretation of left ventricular size between echocardiography and cardiac magnetic resonance in pediatric patients with aortic/mitral regurgitation.
    Barros A, Udine M, Spurney C, Olivieri L, Loke YH.
    Int J Cardiovasc Imaging; 2024 May 15; 40(5):1049-1057. PubMed ID: 38519822
    [Abstract] [Full Text] [Related]

  • 16. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I, Gonçalves A, de Sousa C, Correia AS, Pinho T, Madureira AJ, Martins E, Cardoso JS, Macedo F, Maciel MJ.
    Echocardiography; 2014 Jul 15; 31(6):708-15. PubMed ID: 24460546
    [Abstract] [Full Text] [Related]

  • 17. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
    Cheng S, Choe YH, Ota H, Cui C, Yin G, Lu M, Li L, Chen X, Prasad SK, Zhao S.
    Int J Cardiovasc Imaging; 2018 Apr 15; 34(4):597-605. PubMed ID: 29071521
    [Abstract] [Full Text] [Related]

  • 18. Right ventricular myocardial diastolic dysfunction in different kinds of cardiac hypertrophy: analysis by pulsed Doppler tissue imaging.
    Galderisi M, Severino S, Caso P, Cicala S, Petrocelli A, De Simone L, Mininni N, de Divitiis O.
    Ital Heart J; 2001 Dec 15; 2(12):912-20. PubMed ID: 11838339
    [Abstract] [Full Text] [Related]

  • 19. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications.
    Viliani D, Pozo E, Aguirre N, Cecconi A, Olivera MJ, Caballero P, Jiménez-Borreguero LJ, Alfonso F.
    Int J Cardiovasc Imaging; 2017 Nov 15; 33(11):1771-1780. PubMed ID: 28536896
    [Abstract] [Full Text] [Related]

  • 20. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance.
    Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurada F, Jabbour A, Maceira A, Roussin I, Northridge DB, Kilner PJ, Cook SA, Boon NA, Pepper J, Mohiaddin RH, Newby DE, Pennell DJ, Prasad SK.
    J Cardiovasc Magn Reson; 2012 Jul 28; 14(1):50. PubMed ID: 22839417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.